Health and Fitness Health and Fitness
Tue, November 25, 2008
[ Tue, Nov 25th 2008 ] - Market Wire
Dynavax Announces Listing Transfer to The Nasdaq Capital Market from The Nasdaq Global Market
[ Tue, Nov 25th 2008 ] - Market Wire
AVANIR to Present at the Piper Jaffray 20th Annual Health Care Conference
[ Tue, Nov 25th 2008 ] - Market Wire
Health Net Names Chief Medical Officer
[ Tue, Nov 25th 2008 ] - Market Wire
Aspect Medical Systems Announces Departure of Chief Financial Officer
[ Tue, Nov 25th 2008 ] - Market Wire
Abraxis BioScience Announces Agreement to Re-Acqu .. ABRAXANE; Company Highlights Plans to Initiate Ni
[ Tue, Nov 25th 2008 ] - Market Wire
Optimer Pharmaceuticals to Present at the 20th Annual Piper Jaffray Health Care Conference
[ Tue, Nov 25th 2008 ] - Market Wire
Protalix BioTherapeutics to Present at the Piper Jaffray 20th Annual Health Care Conference
[ Tue, Nov 25th 2008 ] - Market Wire
Italian Cancer Center, Ospedali Riuniti, Chooses .. raOp Medical s Mobetron for Advanced Cancer Care
[ Tue, Nov 25th 2008 ] - Market Wire
CONMED Corporation: CONMED Corporation to Present .. 20th Annual Piper Jaffray Health Care Conference
[ Tue, Nov 25th 2008 ] - Market Wire
Enrollment in Provectus Phase 2 Melanoma Clinical Trial Reaches Halfway Point
[ Tue, Nov 25th 2008 ] - Market Wire
ARIAD to Present at the Piper Jaffray 20th Annual Healthcare Conference
[ Tue, Nov 25th 2008 ] - Market Wire
Acorda Therapeutics to Present at the Piper Jaffray 20th Annual Healthcare Conference
[ Tue, Nov 25th 2008 ] - Market Wire
Cytori Strengthens European Union Sales, Training and Service Operations
[ Tue, Nov 25th 2008 ] - Market Wire
Inspire Announces Webcast of Presentation at Piper Jaffray Conference
Mon, November 24, 2008
[ Mon, Nov 24th 2008 ] - Market Wire
Crucell N.V.: DSM Biologics and Crucell Announce .. PER.C6(R) Licensing Agreement with Gedeon Richter
[ Mon, Nov 24th 2008 ] - Market Wire
Sheffield Teaching Hospitals NHS Trust in U.K. First to Purchase New ZOLL R Series BLS
[ Mon, Nov 24th 2008 ] - Alexa Nuessle
TEEN SUICIDES THIRD LEADING CAUSE OF DEATH Teen Suicide is a Preventable Public Health Problem
[ Mon, Nov 24th 2008 ] - Market Wire
AtriCure to Present at the Piper Jaffray Health Care Conference
[ Mon, Nov 24th 2008 ] - Market Wire
Life Technologies to Present at J.P. Morgan Small/Mid Cap Conference
[ Mon, Nov 24th 2008 ] - Market Wire
New Noninvasive Prenatal Diagnostic Technology Al .. Diseases Such as Cystic Fibrosis Caused by Single
[ Mon, Nov 24th 2008 ] - Market Wire
Mary Stutts to Join Elan as Senior Vice President and Head of Corporate Relations
[ Mon, Nov 24th 2008 ] - Market Wire
DexCom to Present at the Piper Jaffray 20th Annual Health Care Conference
[ Mon, Nov 24th 2008 ] - Market Wire
Roderick de Greef Named Chairman of Cambridge Heart Board of Directors
[ Mon, Nov 24th 2008 ] - Market Wire
LabCorp is Scheduled to Present at the 20th Annual Piper Jaffray Health Care Conference
[ Mon, Nov 24th 2008 ] - Market Wire
Exelixis Announces December 12 Webcast of Its Fourth Annual R&D Day
[ Mon, Nov 24th 2008 ] - Market Wire
TomoTherapy Names Rafael Vaello Vice President of Global Sales
[ Mon, Nov 24th 2008 ] - Market Wire
Alkermes Corporate Presentation to be Webcast at the NASDAQ Investor Program
[ Mon, Nov 24th 2008 ] - Market Wire
U.S. FDA Grants Pralatrexate Orphan Drug Designat .. nt of Patients with Diffuse Large B-Cell Lymphoma
[ Mon, Nov 24th 2008 ] - Market Wire
Celsion Announces the Appointment of Sean Moran as Chief Financial Officer
[ Mon, Nov 24th 2008 ] - Market Wire
Altus Pharmaceuticals to Present at the Piper Jaffray Health Care Conference

Altus Pharmaceuticals to Present at the Piper Jaffray Health Care Conference


Published on 2008-11-24 12:02:21 - Market Wire
  Print publication without navigation


WALTHAM, Mass.--([ BUSINESS WIRE ])--Altus Pharmaceuticals Inc. (NASDAQ: ALTU), announced today that Georges Gemayel, Ph.D., President and CEO of Altus, will speak at the Piper Jaffray Health Care Conference on December 3 in New York City.

Event:    Piper Jaffray Health Care Conference
Presenter: Georges Gemayel, Chief Executive Officer, Altus Pharmaceuticals
Date: Wednesday, December 3, 2008
Time: 11:00 am Eastern Time
Location: New York Palace Hotel, New York City

A webcast of this event will be available to all interested parties on the Altus Pharmaceuticals investor relations website at [ http://ir.altus.com/events.cfm ]. An archived version of the webcast will be available later that day on the Altus investor relations website in the Events and Presentations section.

About Altus Pharmaceuticals Inc.

Altus Pharmaceuticals, headquartered in Waltham, MA, is a biopharmaceutical company focused on the development and commercialization of oral and injectable protein therapeutics for patients with gastrointestinal and metabolic disorders. The Company's website is [ http://www.altus.com ].

Contributing Sources